Neurodegenerative diseases represent a critical challenge in neuroscience, encompassing conditions like Alzheimer’s, Parkinson’s, and Huntington’s diseases. These disorders are characterized by progressive neuronal damage, leading to cognitive, motor, and functional impairments. Current research focuses on unraveling the molecular and genetic mechanisms underlying these diseases, with an emphasis on identifying early biomarkers for timely diagnosis. Advances in therapeutic approaches, such as monoclonal antibodies, RNA-based therapies, and neuroprotective strategies, aim to slow disease progression and improve quality of life. Interdisciplinary collaborations are pivotal in developing innovative interventions, fostering hope for effective solutions to these debilitating conditions.
Title : Scalp acupuncture with functional electrical stimulation for the treatment children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy, Australia
Title : A structure-based strategy to target pathogenic α-synuclein in Parkinson’s disease
Salvador Ventura, Autonomous University of Barcelona, Spain
Title : Rabies: Challenges in taming the beast
Alan C Jackson, University of Calgary, Canada
Title : Designing and managing intelligent and ethical transformed health and social care ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Understanding Alzheimer's disease biomarkers across diverse populations - Opportunities and Insights for novel prevision medicine approaches
Sid O Bryant, Texas College of Osteopathic Medicine and University of North Texas Health Science Center Fort Worth, United States